Abstract
In addition to substance P (SP), 4 other tachykinin peptides have so far been isolated from the mammalian nervous system, namely neurokinin A (NKA), neuropeptide K (NPK), neuropeptide γ (NPγ) and neurokinin B (NKB) (Maggio, 1988; Krause et al., 1989). These tachykinin peptides have a variety of pharmacological effects, indicating smooth muscle contraction, salivation, endothelium-dependent vasodilator actions, and depolarization of central neurons (Erspamer, 1981; Pernow, 1983). These peptides are extensively distributed and play important physiological roles in the mammalian central nervous system (CNS). Several lines of evidence have proposed the existence of multiple tachykinin receptor subtypes in peripheral tissues and the CNS, called NK-1, NK-2 and NK-3 (TABLE I). SP, NKA and NKB are considered to be endogenous ligands of the NK-1, NK-2 and NK-3 subtypes, respectively (Henry, 1987).
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.